HXS:CA:TSX-Horizons S&P 500 Index ETF (CAD)

ETF | US Equity | Toronto Stock Exchange

Last Closing

CAD 75.67

Change

-1.44 (-1.87)%

Market Cap

CAD 0.51B

Volume

0.08M

Analyst Target

N/A
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

The investment seeks to replicate, to the extent possible, the performance of the S&P 500? Index (Total Return), net of expenses.

Inception Date: 30/11/2010

Primary Benchmark: S&P 500 TR CAD

Primary Index:

Gross Expense Ratio: %

Management Expense Ratio: 0.11 %

Unadjusted Closing Price

Adjusted Closing Price

Assets

N/A

Top Holdings

N/A

Symbol Company Name Allocation
CHRO Chromocell Therapeutics Corporation 100.00 %
Top Sectors

N/A

Top Regions

N/A

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-08-02 )

Largest Industry Peers for US Equity

Symbol Name Mer Price(Change) Market Cap
VFV:CA Vanguard S&P 500 Index ETF 0.08 %

N/A

CAD 16.62B
ZSP:CA BMO S&P 500 0.09 %

N/A

CAD 16.02B
XSP:CA iShares Core S&P 500 (CAD Hedg.. 0.11 %

N/A

CAD 10.57B
VUN:CA Vanguard US Total Market 0.16 %

N/A

CAD 9.31B
XUS:CA iShares Core S&P 500 Index ETF 0.11 %

N/A

CAD 7.19B
VSP:CA Vanguard S&P 500 CAD hedged 0.09 %

N/A

CAD 3.46B
QUU:CA Mackenzie US Large Cap Equity .. 0.09 %

N/A

CAD 3.06B
XUU:CA iShares Core S&P US Total Mark.. 0.07 %

N/A

CAD 3.02B
XQQ:CA iShares NASDAQ 100 (CAD Hedged.. 0.39 %

N/A

CAD 3.00B
ZUE:CA BMO S&P 500 (CAD Hedged) 0.09 %

N/A

CAD 2.70B

ETFs Containing HXS:CA

HAC.A:CA 0.00 % 3.14 %

N/A

N/A
HMA:CA 0.00 % 1.27 %

N/A

N/A

Market Performance

  Market Performance vs. Industry/Classification (US Equity) Market Performance vs. Exchange (Toronto Stock Exchange)
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 17.87% 91% A- 82% B
Dividend Return N/A N/A N/A N/A N/A
Total Return 17.87% 82% B 80% B-
Trailing 12 Months  
Capital Gain 25.01% 95% A 85% B
Dividend Return N/A N/A N/A N/A N/A
Total Return 25.01% 91% A- 83% B
Trailing 5 Years  
Capital Gain 103.58% 94% A 87% B+
Dividend Return N/A N/A N/A N/A N/A
Total Return 103.58% 92% A 86% B+
Average Annual (5 Year Horizon)  
Capital Gain 15.05% 95% A 83% B
Dividend Return 15.05% 91% A- 80% B-
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) 13.17% 61% D- 61% D-
Risk Adjusted Return 114.22% 93% A 99% N/A
Market Capitalization 0.51B 89% A- 82% B

Annual Financials (CAD)

Quarterly Financials (CAD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior risk adjusted returns

This stock has performed well, on a risk adjusted basis, compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile.

High market capitalization

This is one of the largest entities in its sector and is among the top quartile. Such companies tend to be more stable.

Positive cash flow

The company had positive total cash flow in the most recent four quarters.

What to not like:
Overpriced on cashflow basis

The stock is trading high compared to its peers on a price to cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.

Overpriced compared to earnings

The stock is trading high compared to its peers on a price to earning basis and is above the sector median.